Literature DB >> 12668572

Detection of ciprofloxacin resistance in Haemophilus influenzae using nalidixic acid and BSAC methodology.

Nigel P Brenwald, Jenny M Andrews, Gail Jevons, Richard Wise.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668572     DOI: 10.1093/jac/dkg200

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.

Authors:  Carmen Puig; José Manuel Tirado-Vélez; Laura Calatayud; Fe Tubau; Junkal Garmendia; Carmen Ardanuy; Sara Marti; Adela G de la Campa; Josefina Liñares
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

Review 2.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

3.  Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.

Authors:  María Pérez-Vázquez; Federico Román; Belén Aracil; Rafael Cantón; José Campos
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

4.  Isolation of antimicrobial resistant bacteria in upper respiratory tract infections of patients.

Authors:  Li-Min Wang; Xiao-Liang Qiao; Liang Ai; Jing-Jing Zhai; Xue-Xia Wang
Journal:  3 Biotech       Date:  2016-08-11       Impact factor: 2.406

5.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.